LEONHARDT HARRY J
Insider CIK 1286102 · HALO SVP, GC and CCO · PSTX GC & Chief Compliance Officer · AMLN SVP, Legal, Compliance and Cor
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 111,700 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 125,283 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 72,568 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 137,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 160,385 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 223,640 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 111,700 | — | $0 | 111,700 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-04 | 16,306 | $4.13 | $67.3K | 214,640 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 80,743 | — | $0 | 230,946 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-02 | 125,283 | — | $0 | 125,283 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-02 | 92,772 | — | $0 | 148,526 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2023-03-01 | 2023-03-02 | 4,323 | $5.35 | $23.1K | 144,203 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-01 | 72,568 | — | $0 | 72,568 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-03-01 | 2022-03-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 137,000 | — | $0 | 137,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-04-13 | 2019-04-15 | 6,875 | — | $0 | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-04-13 | 2019-04-15 | 2,377 | $16.54 | $39.3K | 66,373 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-04-13 | 2019-04-15 | 6,875 | — | $0 | 68,750 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-02-22 | 2019-02-22 | 11,392 | — | $0 | 22,784 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-02-22 | 2019-02-22 | 11,392 | — | $0 | 65,814 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-02-22 | 2019-02-22 | 3,939 | $16.81 | $66.2K | 61,875 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-02-14 | 2019-02-15 | 7,809 | — | $0 | 23,425 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-02-14 | 2019-02-15 | 2,700 | $16.54 | $44.7K | 54,422 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-02-14 | 2019-02-15 | 7,809 | — | $0 | 57,122 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2019-02-12 | 2019-02-14 | 37,538 | — | $0 | 37,538 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2019-02-12 | 2019-02-14 | 71,602 | — | $0 | 71,602 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2019-02-03 | 2019-02-05 | 15,413 | — | $0 | 15,413 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2019-02-03 | 2019-02-05 | 5,658 | $16.12 | $91.2K | 49,313 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2019-02-03 | 2019-02-05 | 15,413 | — | $0 | 54,971 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2018-04-13 | 2018-04-13 | 6,875 | — | $0 | 6,875 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2018-04-13 | 2018-04-13 | 6,875 | — | $0 | 41,935 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2018-04-13 | 2018-04-13 | 2,377 | $19.37 | $46.0K | 39,558 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2018-02-22 | 2018-02-23 | 11,392 | — | $0 | 34,176 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2018-02-22 | 2018-02-23 | 3,939 | $19.28 | $75.9K | 35,060 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2018-02-22 | 2018-02-23 | 11,392 | — | $0 | 38,999 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2018-02-14 | 2018-02-16 | 31,234 | — | $0 | 31,234 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2018-02-14 | 2018-02-16 | 54,780 | — | $0 | 54,780 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2018-02-03 | 2018-02-05 | 15,413 | — | $0 | 30,826 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2018-02-03 | 2018-02-05 | 5,605 | $18.37 | $103.0K | 27,607 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2018-02-03 | 2018-02-05 | 15,413 | — | $0 | 33,212 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2017-04-13 | 2017-04-14 | 6,875 | — | $0 | 13,750 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2017-04-13 | 2017-04-14 | 2,583 | $12.81 | $33.1K | 17,799 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2017-04-13 | 2017-04-14 | 6,875 | — | $0 | 20,382 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 72,925 | — | $0 | 72,925 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 45,568 | — | $0 | 45,568 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2017-02-03 | 2017-02-06 | 15,413 | — | $0 | 46,239 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2017-02-03 | 2017-02-06 | 6,198 | $12.26 | $76.0K | 13,507 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2017-02-03 | 2017-02-06 | 15,413 | — | $0 | 19,705 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2016-04-13 | 2016-04-14 | 6,875 | — | $0 | 20,625 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2016-04-13 | 2016-04-14 | 6,875 | — | $0 | 6,875 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2016-04-13 | 2016-04-14 | 2,583 | $11.76 | $30.4K | 4,292 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-02-03 | 2016-02-04 | 61,652 | — | $0 | 61,652 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-02-03 | 2016-02-04 | 104,603 | — | $0 | 104,603 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2015-04-13 | 2015-04-15 | 225,000 | — | $0 | 225,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2015-04-13 | 2015-04-15 | 27,500 | — | $0 | 27,500 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 18,747 | $31.00 | $581.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 16,863 | $31.00 | $522.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 90,448 | $31.00 | $2.80M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 41,386 | $31.00 | $1.28M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 17,186 | $31.00 | $532.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 8,360 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 1,253 | $31.00 | $38.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 6,437 | $31.00 | $199.5K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 9,552 | $31.00 | $296.1K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 8,614 | $31.00 | $267.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 7,814 | $31.00 | $242.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 26,640 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 3,159 | $31.00 | $97.9K | 4,227 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 727 | $31.00 | $22.5K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 6,361 | $31.00 | $197.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 32,345 | $31.00 | $1.00M | 6,361 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 4,227 | $31.00 | $131.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 90,448 | — | $0 | 90,448 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 9,552 | — | $0 | 9,552 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 1,529 | — | $0 | 7,386 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 15,000 | — | $0 | 38,705 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-03-01 | 2012-03-02 | 1,231 | $17.11 | $21.1K | 23,705 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-02-23 | 2012-02-24 | 2,180 | $17.03 | $37.1K | 24,936 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-22 | 2012-02-24 | 5,800 | — | $0 | 27,116 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-08 | 2012-02-10 | 5,000 | — | $0 | 21,445 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | F Tax w/h | 2012-02-08 | 2012-02-10 | 2,041 | $16.47 | $33.6K | 19,404 | SEC↗ |